NCT00015821
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- North Central Cancer Treatment Group Rochester, Minnesota, United States
Clinical trial condition
Primary Myelofibrosis
Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.
99 public trials
20 recruiting studies
Primary Myelofibrosis trial results
NCT00047190
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT00357305
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, +78 more
- Locations
-
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT00025415
- Conditions
- AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Accelerated Phase Chronic Myelogenous Leukemia, +170 more
- Locations
-
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT01371617
- Conditions
- Bone Marrow Diseases, Fibrosis, Bone Marrow, Hematologic Diseases, +3 more
- Locations
-
- Arizona Mayo Clinic Scottsdale, Arizona, United States
- Stanford University School of Medicine, Division of Hematology Palo Alto, California, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00799461
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
NCT06468033
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Levine Cancer Institute Charlotte, North Carolina, United States
- University of Yamanashi Hospital Chūō, Yamanashi, Japan
Active, Not Recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers Chandler, Arizona, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT04717414
- Conditions
- Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
- Locations
-
- Local Institution - 110 Los Angeles, California, United States
- Local Institution - 135 Orlando, Florida, United States
- Local Institution - 133 Plantation, Florida, United States
- Local Institution - 112 Chicago, Illinois, United States
Active, Not Recruiting
CINC424A2X01B Rollover Protocol
NCT02386800
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Hemolytic, +31 more
- Locations
-
- Novartis Investigative Site Darlinghurst, New South Wales, Australia
- Novartis Investigative Site Herston, Queensland, Australia
- Novartis Investigative Site Wooloongabba, Queensland, Australia
- Novartis Investigative Site Bedford Park, South Australia, Australia